Hypokalemia is associated with lengthening of QT interval in psychiatric patients on admission

Psychiatry Research

Volumn 169, Issue 3, 2009, Pages 257-260

  Trojak, Benoit ^a   Astruc, Karine ^a   Pinoit, Jean Michel ^a   Chauvet Gelinier, Jean Christophe ^a   Ponavoy, Eddy ^a   Bonin, Bernard ^a   Gisselmann, André ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Catecholamine; Potassium; Sympathetic; Ventricular arrhythmia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; HALOPERIDOL; MESORIDAZINE; NEUROLEPTIC AGENT; PIMOZIDE; POTASSIUM; QUETIAPINE; RISPERIDONE; THIORIDAZINE; ZIPRASIDONE;

ADULT; AGE; AGED; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG USE; ELECTROCARDIOGRAM; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPOKALEMIA; LONG QT SYNDROME; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT ADMISSION; POTASSIUM; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70349230749     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.06.031     Document Type: Article

References (25)

1. Arizona Center for Education and Research on Therapeutic (CERT). The University of Arizona College of Pharmacy. QT drug lists revised 03/01/2006. [on line] Available at: http://www.qtdrugs.org. Accessed May 29, 2007.
2. Bazett H. An analysis of time-relations of electrocardiogram. Heart 7 (1920) 353-370
3. Benedict C.R. The QT interval and drug-associated torsades de pointes. Drug Investigation 5 (1993) 69-79
4. Brown M.J., Brown D.C., and Murphy M.B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. New England Journal of Medecine 309 (1983) 1414-1419
5. Carl G., and Holzbach E. Reversible hypokalemia and hypomagnesemia during alcohol withdrawal syndrome. Nervenarzt 65 (1994) 206-211
6. De Ponti F., Poluzzi E., Cavalli A., Recanatini M., and Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes. Drug Safety 25 (2002) 263-286
7. D'Silva J.L. The action of adrenaline on serum potassium. Journal of Physiology 82 (1934) 393-398
8. Facchini M., Sala L., Malfatto G., Bragato R., Redaelli G., and Invitti C. Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa. International Journal of Cardiology 106 (2006) 170-176
9. Fukui S., Katoh H., Tsuzuki N., Otani N., Ooigawa H., Toyooka T., Ohnuki A., Miyazawa T., Nawashiro H., and Shima K. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrage. Critical Care 7 (2003) R7-R12
10. Glassman A.H., and Bigger T. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. American Journal of Psychiatry 158 (2001) 1774-1782
11. Gowda R.M., Khan I.A., Wilbur S.L., Vasavada B.C., and Sacchi T.J. Torsade de pointes: the clinical considerations. International Journal of Cardiology 96 (2004) 1-6
12. Haddad P.E., and Anderson I.A. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62 (2002) 1649-1671
13. Hatta K., Takahashi T., Nakamura H., Yamashiro H., Endo H., Fujii S., Fukami G., Masui K., Asukai N., and Yonezawa Y. Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydratation, hypokalemia, leukocytosis and elevated serum muscle enzymes. European Archives of Psychiatry and Clinical Neuroscience 248 (1998) 180-188
14. Hatta K., Takahashi T., Nakamura H., Yamashiro H., Asukai N., and Yonezawa Y. Hypokalemia and agitation in acute psychotic patients. Psychiatry Research 86 (1999) 85-88
15. Hatta K., Takahashi T., Nakamura H., Yamashiro H., and Yonezawa Y. Prolonged QT interval in acute psychotic patients. Psychiatry Research 94 (2000) 279-285
16. Henry J.B. Clinical diagnosis and management by laboratory methods. 19th ed. (1996), Saunder W.B., Philadelphia
17. Kemperman C.J., Kuilman M., and Njio L.K. A retrospective and explorative study of hypokalemia in psychiatric disorders: a beta 2-receptor related phenomenon. European Archives of Psychiatry and Neurological Sciences 237 (1988) 161-165
18. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., and Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Journal of the American Medical Association 270 (1993) 2590-2597
19. Mayuga K.A., Parker M., Sukthanker N.D., Perlowski A., Schwartz J.B., and Kadish A.H. Effects of age and gender on the QT response to exercise. American Journal of Cardiology 87 (2001) 163-167
20. Medbo J.I., and Sejersted O.M. Plasma potassium changes with high intensity exercise. Journal of Physiology 421 (1990) 105-122
21. Reilly J.G., Ayis S.A., Ferrier I.N., Jones S.J., and Thomas S.H.L. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355 (2000) 1048-1052
22. Stasiukyniene V. Blood plasma potassium, sodium and magnesium levels in chronic alcoholism during alcohol withdrawal. Medicina (Kaunas) 38 (2002) 892-895
23. Viskin S., Justi D., Halkin, and Zeltser D. Long QT syndrome caused by noncardiac drugs. Progress in Cardiovascular Diseases 45 (2003) 415-427
24. Witchel H.J., Hancox J.C., and Nutt D.J. Psychotropic drugs, cardiac arrhythmia, and sudden death. Journal of Clinical Psychopharmacology 23 (2003) 58-77
25. Zarate C.A., and Patel J. Sudden cardiac death and antipsychotic drugs. Archives of General Psychiatry 58 (2001) 1168-1171